BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khoshpouri P, Habibabadi RR, Hazhirkarzar B, Ameli S, Ghadimi M, Ghasabeh MA, Menias CO, Kim A, Li Z, Kamel IR. Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up. RadioGraphics 2019;39:1938-64. [DOI: 10.1148/rg.2019180213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Cebada Chaparro E, Lloret del Hoyo J, Méndez Fernández R. Chronic cholangitis: Differential diagnosis and role of MRI. Radiología (English Edition) 2020;62:452-63. [DOI: 10.1016/j.rxeng.2020.08.002] [Reference Citation Analysis]
2 Mccain JD, Chascsa DM, Lindor KD. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021;9:53-66. [DOI: 10.1080/21678707.2021.1898370] [Reference Citation Analysis]
3 Aboughalia H, Kim HH, Dick AAS, Pacheco MC, Cilley RE, Iyer RS. Pediatric biliary disorders: Multimodality imaging evaluation with clinicopathologic correlation. Clin Imaging 2021;75:34-45. [PMID: 33493735 DOI: 10.1016/j.clinimag.2021.01.006] [Reference Citation Analysis]
4 Marks RM, Fowler KJ, Bashir MR. MR Imaging of Diffuse Liver Disease. Magn Reson Imaging Clin N Am 2021;29:347-58. [PMID: 34243922 DOI: 10.1016/j.mric.2021.05.004] [Reference Citation Analysis]
5 Welle CL, Navin PJ, Olson MC, Hoodeshenas S, Torbenson MS, Venkatesh SK. MR elastography in primary sclerosing cholangitis: a pictorial review. Abdom Radiol (NY) 2022. [PMID: 35567617 DOI: 10.1007/s00261-022-03529-x] [Reference Citation Analysis]
6 Mahalingam S, Langdon J, Muniraj T, Do A, Guo Y, Spektor M, Mathur M. Endoscopic Retrograde Cholangiopancreatography: Deciphering the Black and White. Curr Probl Diagn Radiol 2021;50:74-84. [PMID: 32063296 DOI: 10.1067/j.cpradiol.2020.01.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ghadimi M, Habibabadi RR, Hazhirkarzar B, Shaghaghi M, Ameli S, Khoshpouri P, Ghasabeh MA, Gurakar A, Pawlik TM, Kamel IR. Advances in Imaging of Diffuse Parenchymal Liver Disease. J Clin Gastroenterol 2020;54:682-95. [PMID: 32554990 DOI: 10.1097/MCG.0000000000001380] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cao JY, Artunduaga M, Schooler GR. Hepatic manifestations of systemic disease: an imaging-based review. Pediatr Radiol 2021. [PMID: 34797394 DOI: 10.1007/s00247-021-05222-5] [Reference Citation Analysis]
9 Duan T, Jiang HY, Ling WW, Song B. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review. World J Gastroenterol 2022; 28(16): 1625-1640 [DOI: 10.3748/wjg.v28.i16.1625] [Reference Citation Analysis]
10 Metra BM, Guglielmo FF, Halegoua-DeMarzio DL, Civan JM, Mitchell DG. Beyond the Liver Function Tests: A Radiologist's Guide to the Liver Blood Tests. Radiographics 2021;:210137. [PMID: 34797734 DOI: 10.1148/rg.210137] [Reference Citation Analysis]
11 Dong B, Chen Y, Lyu G, Qin R. Liver stiffness measurement as a quantitative method for liver fibrosis in children with non-alcoholic fatty liver disease: A meta-analysis. J Paediatr Child Health 2021. [PMID: 34554611 DOI: 10.1111/jpc.15751] [Reference Citation Analysis]
12 Reiter R, Shahryari M, Tzschätzsch H, Klatt D, Siegmund B, Hamm B, Braun J, Sack I, Asbach P. Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography. Sci Rep 2021;11:9820. [PMID: 33972639 DOI: 10.1038/s41598-021-89372-4] [Reference Citation Analysis]
13 Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun 2021;4:100074. [PMID: 33490938 DOI: 10.1016/j.jtauto.2020.100074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Khoshpouri P, Ghadimi M, Rezvani Habibabadi R, Motaghi M, Venkatesh BA, Shaghaghi M, Pandey A, Hazhirkarzar B, Ameli S, Ghasabeh MA, Pandey P, Kamel IR. Cross-sectional imaging in patients with primary sclerosing cholangitis: Single time-point liver or spleen volume is associated with survival. Eur J Radiol 2020;132:109331. [PMID: 33091863 DOI: 10.1016/j.ejrad.2020.109331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Evrimler S, Swensson JK, Are VS, Tirkes T, Vuppalanchi R, Akisik F. Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging. Abdom Radiol (NY) 2021;46:2433-43. [PMID: 33135100 DOI: 10.1007/s00261-020-02839-2] [Reference Citation Analysis]
16 Yuan J, Xu Y, Li H, Guo Q, Li G, Chai W, Zhang Z, Liu R, Yuan Q. Magnetic Resonance Imaging and Serum AFP-L3 and GP-73 in the Diagnosis of Primary Liver Cancer. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/1192368] [Reference Citation Analysis]